Hyun-Seung Kim Selected Research

Hyun-Seung Kim Research Topics

Disease

6	Cataract (Cataracts) 04/2024 - 02/2011
3	Meibomian Gland Dysfunction 08/2022 - 01/2021
3	Inflammation (Inflammations) 06/2022 - 04/2006
2	Dry Eye Syndromes (Dry Eye Syndrome) 08/2022 - 11/2018
2	Wounds and Injuries (Trauma) 06/2022 - 08/2003
2	Infections 12/2021 - 03/2014
2	Necrosis 01/2020 - 03/2014
2	Hypertension (High Blood Pressure) 01/2019 - 04/2005
2	Pterygium 01/2019 - 11/2018
2	Heart Failure 05/2005 - 08/2003
2	Atherosclerotic Plaque (Atheroma) 05/2005 - 12/2002
2	Coronary Artery Disease (Coronary Atherosclerosis) 02/2005 - 12/2002
1	Dyslipidemias (Dyslipidemia) 07/2022
1	Burns 06/2022
1	Chemical Burns (Chemical Burn) 06/2022
1	Corneal Neovascularization 06/2022
1	Trichuriasis 12/2021
1	Peri-Implantitis 01/2021
1	Glaucoma 12/2020
1	Coma (Comas) 04/2020
1	Myopia 04/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Diabetes Mellitus 01/2019
1	Blepharoptosis (Ptosis, Eyelid) 01/2019
1	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2018
1	AIDS-Related Complex (ARC) 04/2015
1	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 12/2011
1	Astigmatism 02/2011
1	Cardiac Arrhythmias (Arrythmia) 02/2006
1	Sick Sinus Syndrome 02/2006
1	Acute Coronary Syndrome 05/2005
1	Ventricular Remodeling 05/2005
1	Stroke (Strokes) 05/2005
1	Limbal Stem Cell Deficiency 04/2005
1	Chest Pain (Chest Pains) 08/2003
1	Chlamydophila Infections 12/2002
1	Atherosclerosis 12/2002

Drug/Important Bio-Agent (IBA)

2	LipidsIBA 07/2022 - 01/2021
2	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 05/2005 - 12/2002
2	Matrix Metalloproteinases (MMPs)IBA 05/2005 - 12/2002
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2022
1	AlkaliesIBA 06/2022
1	Hyaluronic Acid (Hyaluronan)IBA 06/2022
1	Sulfhydryl Compounds (Thiols)IBA 06/2022
1	HydrogelsIBA 06/2022
1	Therapeutic UsesIBA 06/2022
1	AnthelminticsIBA 12/2021
1	oxantel pamoateIBA 12/2021
1	Albendazole (Albenza)FDA Link 12/2021
1	graphene oxideIBA 01/2021
1	Ophthalmic Solutions (Eye Drops)IBA 12/2020
1	Lubricant Eye Drops (Artificial Tears)IBA 12/2020
1	Dihydrotachysterol (AT 10)IBA 04/2020
1	2-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA 01/2020
1	InterleukinsIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Substance PIBA 01/2020
1	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Vitamin D FDA LinkGeneric 01/2019
1	ORALIT (ORS)IBA 01/2019
1	25-hydroxyvitamin DIBA 11/2018
1	hydroxide ionIBA 11/2018
1	TitaniumIBA 04/2015
1	titanium nitride (titanium nitride (TiN))IBA 04/2015
1	zirconium nitrideIBA 04/2015
1	Adenosine Triphosphatases (ATPase)IBA 03/2014
1	acceleratory factor from growth hormone (AcG)IBA 12/2011
1	Polymethyl Methacrylate (Sol)IBA 02/2011
1	CytokinesIBA 04/2006
1	ChemokinesIBA 04/2006
1	Flecainide (Tambocor)FDA LinkGeneric 02/2006
1	Peptide Hydrolases (Proteases)FDA Link 05/2005
1	Metalloproteases (Metalloproteinases)IBA 05/2005
1	CollagenIBA 04/2005
1	Antihypertensive Agents (Antihypertensives)IBA 04/2005
1	Amlodipine (Norvasc)FDA LinkGeneric 04/2005
1	EnzymesIBA 08/2003
1	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2003
1	Neurotransmitter Agents (Neurotransmitter)IBA 08/2003
1	GelatinasesIBA 12/2002
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 12/2002

Therapy/Procedure

2	Intraocular Lenses (Intraocular Lens) 12/2011 - 02/2011
1	Corneal Transplantation (Keratoplasty) 04/2024
1	Multifocal Intraocular Lenses 01/2022
1	Mass Drug Administration 12/2021
1	Lenses 04/2020
1	Refractive Surgical Procedures 01/2020
1	Lasers (Laser) 01/2020
1	Laser In Situ Keratomileusis (LASIK) 01/2020
1	Slit Lamp 11/2018
1	Hematopoietic Stem Cell Transplantation 11/2018
1	Transplantation 04/2005
1	Stents 02/2005